Collagen and keratin are much longer and more complex proteins that provide skin strength, elasticity, and resilience
L.JurcisekJ
GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective treatment options for obesity
Those treated with tirzepatide had an average weight loss of 15% to 20% of their starting body weight over 72 weeks (about 16.5 months)
Medicare will only approve weight loss drugs for those with obesity that occurs alongside cardiovascular disease
Clinical Application Guidance: Therapeutic selection should be individualized based on patient-specific factors, such as cardiovascular status, renal function, administration route preferences, and tolerability, with ongoing attention to emerging evidence to refine treatment strategies